016580 — Whanin Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapTurnaround

Market Cap
KR₩208bn
Enterprise Value
KR₩146bn
Revenue
KR₩255bn

Annual balance sheet for Whanin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	146,043	87,292	78,066	52,062	63,580
Net Total Accounts Receivable
Net Total Receivables	63,120	72,326	78,947	75,709	66,547
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	242,412	197,422	212,101	201,297	228,271
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	46,869	109,854	131,211	149,218	144,059
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	353,189	369,375	401,227	424,706	478,891
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,900	31,750	40,028	42,376	56,501
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	36,249	35,863	43,019	48,704	57,884
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	316,939	333,511	358,207	376,002	421,007
Total Liabilities & Shareholders' Equity	353,189	369,375	401,227	424,706	478,891
Total Common Shares Outstanding